The abstract is read at the publisher; the summary is JClub's.
Comprehensive genomic surveillance for pathogen whole-genome sequencing is linked to higher upfront and steady investment, but scenario-based analysis suggests it may avert large-scale outbreaks and yield long-term savings.
- Why it matters: Health systems must choose between routine genomic surveillance and outbreak-triggered sequencing, balancing ongoing costs against the financial risk of missing an outbreak early.
- What they did: The Personal View reviews economic analyses and uses scenario-based sensitivity analysis and cost comparisons to contrast comprehensive versus selective surveillance and outbreak sequencing.
- The result: The analysis implies that, in many settings, investing in comprehensive surveillance could become economically sound by reducing the likelihood and cost of large outbreaks.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.